Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Psoriasis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT03598790
What this trial is testing

Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Chronic Plaque PsoriasisModerate to Severe Chronic Plaque Psoriasis
UCB Biopharma SRL 1,353
Early research (Phase 1)Study completedNCT02801435
What this trial is testing

Icotinib Hydrochloride Cream in Patients With Mild to Moderate Psoriasis

Who this might be right for
Psoriasis
Betta Pharmaceuticals Co., Ltd. 41
Not applicableStudy completedNCT02271971
What this trial is testing

Effect of Vitamin D Supplementation on Metabolic Parameters of Patients With Psoriasis

Who this might be right for
PsoriasisMetabolic SyndromeVitamin D Deficiency
Pontificia Universidad Catolica de Chile 39
Post-approval studies (Phase 4)Study completedNCT02749370
What this trial is testing

Study to Evaluate the Efficacy of Etanercept Treatment in Adults Who Failed Therapy With Apremilast

Who this might be right for
Plaque Psoriasis
Amgen 80
Large-scale testing (Phase 3)Active Not RecruitingNCT03997786
What this trial is testing

Tildrakizumab in Pediatric Subjects With Chronic Plaque Psoriasis

Who this might be right for
Moderate-to-severe Chronic Plaque Psoriasis
Sun Pharmaceutical Industries Limited 135
Large-scale testing (Phase 3)Not Yet RecruitingNCT07432854
What this trial is testing

A Clinical Study Evaluating the Efficacy and Safety of CMS-D001 Tablets in the Treatment of Adult Patients With Moderate to Severe Plaque-type Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
Dermavon Holdings Limited 540
Testing effectiveness (Phase 2)Study completedNCT04102241
What this trial is testing

Efficacy and Safety Study of Hemay005 in Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Tianjin Hemay Pharmaceutical Co., Ltd 216
Not applicableUnknownNCT01753245
What this trial is testing

Analysis Of The Influence Of Metabolic Syndrome On Treatment Efficacy With Anti-Tnf In Moderate-Severe Psoriasis In Real Clinical Practice.

Who this might be right for
Psoriasis VulgarisMetabolic Syndrome
Juan Ruano 300
Large-scale testing (Phase 3)Study completedNCT04175613
What this trial is testing

A Long-term Extension Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Amgen 160
Large-scale testing (Phase 3)Not Yet RecruitingNCT06643260
What this trial is testing

Study in Moderate-to-Severe Plaque Psoriasis With Piclidenoson to Study Safety and Efficacy

Who this might be right for
Plaque Psoriasis
Can-Fite BioPharma 705
Large-scale testing (Phase 3)Ended earlyNCT01708590
What this trial is testing

Efficacy, Safety, and Withdrawal and Retreatment With Brodalumab in Moderate to Severe Plaque Psoriasis Subjects

Who this might be right for
Psoriasis
Bausch Health Americas, Inc. 661
Testing effectiveness (Phase 2)Ended earlyNCT05511519
What this trial is testing

Study of ATI-450 vs Placebo in Patients With Moderate to Severe Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Aclaris Therapeutics, Inc. 47
Testing effectiveness (Phase 2)Looking for participantsNCT07489885
What this trial is testing

Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
InventisBio Co., Ltd 75
Not applicableStudy completedNCT03059953
What this trial is testing

Treatment With APRemilast in Moderate psoriAsIS in Real Life clinicAL Practice (The 'APRAISAL' Study)

Who this might be right for
Moderate Plaque Psoriasis
Genesis Pharma S.A. 302
Early research (Phase 1)Study completedNCT00382512
What this trial is testing

Evaluate the Effects of Efalizumab on Immune Responses in Subjects With Moderate Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Genentech, Inc. 60
Testing effectiveness (Phase 2)Study completedNCT01154101
What this trial is testing

Study of the Clinical Activity, Safety, and Tolerability of SRT2104 in Subjects With Moderate to Severe Plaque-Type Psoriasis

Who this might be right for
Psoriasis
Sirtris, a GSK Company 40
Post-approval studies (Phase 4)Study completedNCT02690701
What this trial is testing

Study to Evaluate the Effect of Secukinumab Compared to Placebo on Aortic Vascular Inflammation in Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
Novartis Pharmaceuticals 91
Not applicableUnknownNCT05144165
What this trial is testing

Systemic Treatment of Moderate-to-severe Psoriasis in Adults: Update of the French Guidelines

Who this might be right for
PsoriasisPsoriasis PalmarisPsoriasis Inverse+8 more
Centre of Evidence of the French Society of Dermatology 30
Not applicableStudy completedNCT00930592
What this trial is testing

Peds Metabolic Syndrome in Psoriasis

Who this might be right for
PsoriasisMetabolic Syndrome
Tufts Medical Center 42
Not applicableStudy completedNCT01076192
What this trial is testing

Study of Adalimumab (HUMIRA®) in Patients With Moderate to Severe Psoriasis (PS) in Spain (PROMISE)

Who this might be right for
Moderate-to-severe Chronic Plaque Psoriasis
AbbVie (prior sponsor, Abbott) 547
Next Page